Making a comeback after a negative FDA experience
This article was originally published in Clinica
Executive Summary
Negative feedback from the FDA does not necessarily mean disaster. Glenn Neuman, director of scientific affairs at New World Regulatory Solutions, gives advice on how to get a company back on its feet after a knock-back